Pharmaceutical Dosage Forms - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Pharmaceutical Dosage Forms

Description:

Solutions one homogenous phase, prepared by dissolving one or more solutes in a solvent ... Melting/dissolving at body temperature ... – PowerPoint PPT presentation

Number of Views:7496
Avg rating:3.0/5.0
Slides: 42
Provided by: tantaph
Category:

less

Transcript and Presenter's Notes

Title: Pharmaceutical Dosage Forms


1
Pharmaceutical Dosage Forms
  • Presented
  • By
  • Prof. Dr. Sanaa A. El-Gizawy

2
Pharmaceutics
  • Pharmaceutics is the science of dosage form
    design.
  • There are many chemicals with known
    pharmacological properties but a raw chemical is
    of no use to a patient.
  • Pharmaceutics deals with the formulation of a
    pure drug substance into a dosage form.

3
Active Drug Substance
  • (Active pharmaceutical ingredient - API)
  • Chemical compound with pharmacological (or other
    direct effect ) intended for use in diagnosis,
    treatment or prophylaxis of diseases.
  • International non-proprietary names (INN, generic
    names)

4
Direct clinical use of the active drug substances
as they are is rare due to a number of good
reasons
  • API handling can be difficult or impossible
    (e.g., low mg and ?g doses)
  • Accurate drug dosing can be difficult or
    impossible
  • API administration can be impractical, unfeasible
    or not according to the therapeutic aims
  • Some API can benefit from reducing the exposure
    to the environmental factors (light, moisture),
    or they need to be chemically stabilised due to
    the inherent chemical instability

5
Direct clinical use of the active drug substances
as they are is rare due to a number of good
reasons
  • API can be degraded at the site of administration
    (e.g., low pH in stomach)
  • API may cause local irritations or injury when
    they are present at high concentrations at the
    site of administration
  • API can have unpleasant organoleptic qualities
    (taste, smell compliance!)
  • Administration of active substance would mean to
    have no chance for modification (improvement) of
    its PK profile

6
From drug substance to pharmaceutical preparation
  • Besides the choice of the active drug substance,
    you need to also make a responsible decision
    regarding the route of administration and the
    DOSAGE FORM (drug delivery system) wrong choice
    can cause failure of therapy
  • You should also be able to handle and administer
    the drug properly or advise the patient about it
    wrong use can cause failure of therapy

7
Excipients
  • Excipients (inactive pharmaceutical ingredients)
  • Its selection depends on technological,
    biopharmaceutical and/or stability reasons.
  • Diluents/fillers, binders, lubricants, coatings,
    preservatives, colorants and flavouring agents

8
Pharmaceutical dosage form
  • Pharmaceutical dosage form
  • Determines the physical form of the final
    pharmaceutical preparation
  • Is a drug delivery system which is formed by
    technological processing (drug formulation)
  • Must reflect therapeutic intentions, route of
    administrations, dosing etc.

9
Pharmaceutical preparation (PP)
  • Pharmaceutical preparation (PP)
  • particular pharmaceutical product containing
    active and inactive pharmaceutical ingredients
    formulated into the particular dosage form.
  • Packed and labelled appropriately
  • Two major types of PP according the origin
  • Manufactured in large scales by pharmaceutical
    industry (original and generic preparations)
  • Compounded individually in compounding pharmacies

10
1- Pharmaceutical preparations manufactured by
pharmaceutical industry
  • 1.1- Original pharmaceutical preparations
  • undergo full and very extensive pharmacological/
    toxicological and pharmaceutical pre-clinical and
    clinical development and evaluation
  • particularly important is the proof of
    effectiveness and safety

11

1.2- Generic pharmaceutical preparations
(authorised copies of original preparations)
  • - Can be released after the expiration of the
    patent protection of the original preparation
  • The approval for clinical use is easier due to
    the prior experience with the original
    preparation
  • Must be pharmaceutically equivalent same API,
    dose, pharmaceutical dosage form and the same
    route of administration as in original
    preparation
  • Must be clinically bioequivalent i.e. it must be
    of very close PK profile as original preparation.
    PK parameters (Cmax, tmax, AUC) are within 80-125
    range as compared with the original
    preparation.

12
2- Pharmaceutical preparations compounded
individually
  • These PP are compounded individually for a
    particular patient according to the physician's
    prescription in a pharmacy licensed for
    compounding
  • In contrast to the past, they are used rather
    rarely and mostly in specific situations
  • It is highly advisable that whenever the
    particular suitable PP is approved and
    commercially available it should be preferred
    over the compounding
  • The major disadvantage is the lack of
    standardization (it is always a single-patient
    batch), unavailability of rigorous QC testing
    and the appropriate clinical evaluation.

13
The individually compounded PP can be a justified
choice when
  • The drug in a particular dosage form is not
    commercially available on the market
  • The extraordinary low or high dose is needed
    (young children, elderly people, special
    situations e.g., intoxications). In this case
    right dosage strength need not be readily
    commercially available for every patient
  • The patient suffers from the allergy on a
    specific excipients (e.g., lactose a filler,
    some colorizing/flavouring or antimicrobial
    agents - parabens) or another drug appearing in
    the PP
  • Patient is unable to use a PP in its commercially
    available dosage form (e.g., children, elderly)

14
Classification of pharmaceutical dosage forms
according to physical properties
  • Gaseous dosage forms
  • Liquid dosage forms
  • Semisolid dosage forms
  • Solid dosage forms

15
Gases
  • Medicinal gases, inhalation/volatile anaesthetics
    (vaporised before administration by inhalation)
  • Aerodispersions of solid particles (e.g.,
    antiasthmatic inhalations) or liquid particles
    (antiasthmatic inhalations or sprays)

16
Liquids
  • Solutions one homogenous phase, prepared by
    dissolving one or more solutes in a solvent
  • Emulsions
  • a dispersion system consisting of two immiscible
    liquids
  • o/w or w/o
  • cloudy appearance
  • Suspensions
  • A dispersion system where solid particles
    (dispersed phase) are dispersed in liquid phase
    (dispersion medium)
  • According to the size of dispersed particles (1
    nm- 0,5 mm) a molecular, colloidal and coarse
    dispersions can be distinguished
  • May require shaking before administration
  • Not intended for systemic administration of drugs
    with high potency

17
Semisolid dosage forms1- Unshaped (without
specific physical shape)
  • Gels -A semisolid systems in which a liquid phase
    is constrained within a 3D cross-linked matrix.
  • Creams semisolid emulsion systems (o/w, w/o)
    containing more than 10 of water.
  • o/w creams - more comfortable and cosmetically
    acceptable as they are less greasy and more
    easily water washable
  • w/o creams accommodate and release better
    lipophilic API, moisturizing, Cold creams

18
Semisolid dosage forms1- Unshaped (without
specific physical shape)
  • Ointments semisolid dosage forms with the
    oleaginous (hydrocarbon), water-soluble or
    emulsifying base
  • Oleaginous (hydrocabon) base Petrolatum
    (Vaseline white, yellow)
  • Water-soluble base Polyethylenglycol (PEG)-
    ointment syn. macrogol ointments
  • Pastes semisolid dispersion system, where a
    solid particles (gt 25, e.g. ZnO) are dispersed
    in ointments mostly oleaginous (Petrolatum)

19
Semisolid dosage forms
  • 2- Shaped
  • Suppositories (for rectal administration)
  • different shapes
  • Melting/dissolving at body temperature
  • Oleaginous (cacao butter, adeps neutralis) or
    aqueous (PEGs, glycerinated gelatine)
  • Pessaries (vaginal suppositories)
  • Similar as above, PEGs or glycerinated gelatine
    are often used as base.

20
Solid Dosage Forms
  • Unshaped (without specific shape)
  • - powders for external/internal use
  • Shaped
  • Tablets
  • Capsules
  • Implantates (Sterile disks inserted surgically
    into body tissues and designed to release drug(s)
    over extended period of time)
  • Transdermal patches
  • Lozenges (consists of sugar and gum to medicate
    the mouth and throate)

21
Classification of pharmaceutical dosage forms
according to the route of administration
  • for systemic administration
  • Peroral (p.o)
  • Sublingual (S.L) and buccal.
  • Rectal
  • Parenteral
  • Transdermal
  • Inhalation

22
Classification of pharmaceutical dosage forms
according to the route of administration
  • for local administration
  • Topical (on the skin or mucosa)
  • Into/onto - the eye, nose, ear
  • - the oral cavity
  • - the vagina, rectum
  • - the brochi
  • - the skin
  • Local parenteral (viz Parenteral above)
  • Oral (local effect within GIT antacids,
    adsorbents)

23
Prescription Writing
  • The prescription is one of the most important
    therapeutic transactions between physician and
    patient.
  • The art of prescription writing is an ancient
    inheritance.
  • The ancients started their prescription with an
    appeal to the gods for its success.
  • The ancient symbol, Rx, signifying the appeal,
    was established centuries ago and has been
    carried down to the present time.

24
Prescription Writing
  • To avoid undesirable and/or serious effects on
    the patient, both physician and pharmacist must
    render the highest of professional services.
  • Accurate diagnosis proper selection of
    medication, dosage form and route of
    administration proper size and timing of dose
    precise dispensing accurate labeling and
    correct packaging all must be provided.

25
Parts of prescriptions
26
  • For Arthur H. Recipe
  • Take thou
  • Potassium Acetate of.............................o
    ne drachm.
  • Of Solution of Acetate of Ammonium........three
    and a half drachms.
  • Of Spirits of Nitrous Ether.......................
    ....two drachms.
  • Of Infusion of Buchu (a quantity sufficient) up
    to four ounces.........
  • Signa -Mix. Let a mixture be made.
  • Label -One drachm three times a day after meals.

27
Parts of prescriptions
28
Form of the Written Prescription
  • A prescription consists of the superscription,
    the inscription, the subscription, the signa, and
    the name of the prescriber
  • 1- Superscription
  • The date when the prescription order is written
    the name, address and age of the patient and the
    symbol Rx (an abbreviation for "recipe," the
    Latin for "take")

29
Form of the Written Prescription
  • 2- Inscription
  • The body of the prescription, containing the name
    and amount or strength of each ingredient.
  • 3- Subscription
  • The directions to the pharmacist, usually
    consisting of a short sentence such as "make a
    solution," "mix and place into 10 capsules," or
    "dispense 10 tablets."

30
Form of the Written Prescription
  • 4- Signature
  • From the Latin "signa," meaning "write," "make,"
    or "label," this sections contains the directions
    to the patient.
  • These should always be written in English
    however, physicians continue to insert Latin
    abbreviations, e.g. "1 cap t.i.d. pc," which the
    pharmacist translates into English, "take one
    capsule three times daily after meals." Since the
    pharmacist always writes the label in English,
    the use of such abbreviations or symbols should
    be discouraged.

31
Form of the Written Prescription
  • Follow 4- Signature
  • The instruction, "take as directed," is not
    satisfactory and should be avoided.
  • The directions to the patient should include a
    reminder of the intended purpose of the
    medication by including such phrases as "for
    pain," "for relief of headache," or "to relieve
    itching"

32
Form of the Written Prescription
  • 5- Labeling
  • When the physician wants his patient to know the
    name of the drug, the box on the prescription
    form marked "label" should be checked.
  • 6- Refills
  • The physician should designate the number of
    refills he wishes the patient to have.

33
Proprietary vs. Non-Proprietary ("Generic")
Prescriptions
  • In recent years, some hospitals and private
    physicians are indicating on the prescription
    their willingness or desire that the pharmacist
    dispense a non-proprietary or "generic-named"
    preparation instead of the trade name item
    written on the prescription. Some have a box on
    the prescription designated "N.P.P." In this way,
    the pharmacist can use a form of the drug which
    may be less expensive to the patient.

34
Types of Drugs
  • Legend Drugs These drugs may not be dispensed by
    a pharmacist without a prescription from a
    physician.
  • Controlled Drugs In addition to requiring a
    prescription, these drugs require additional
    safeguards for storage. Refills are also limited.
  • Over-the-Counter (OTC) Drugs These drugs do not
    require a prescription.

35
Controlled Substances
  • Schedules of Controlled Drugs These drugs are
    divided into five schedules.
  • Drugs can be scheduled, unscheduled, or moved
    from one schedule to another as the need arises.
  • Schedule I
  • Drugs in this schedule have a high abuse
    potential (narcotic and hallucination effects).
    Examples are heroin, marijuana.

36
Controlled Substances
  • Schedule II
  • Drugs in this schedule have a high abuse
    potential with severe psychic or physical
    dependence liability. Included are certain
    narcotic analgesics, stimulants, and depressant
    drugs. Examples are opium, morphine, codeine,
    hydromorphone, methadone, meperidine, oxycodone,
    anileridine, cocaine, amphetamine,
    methamphetamine, phenmetrazine, methylphenidate,
    amobarbital, pentobarbital, secobarbital,
    methaqualone, and phencyclidine.

37
Controlled Substances
  • Schedule III
  • Drugs in this schedule have an abuse potential
    less than those in Schedules I and II and include
    compounds containing limited quantities of
    certain narcotic analgesic drugs, and other drugs
    such as barbiturates, glutethimide, methyprylon,
    and chlorphentemine. Any suppository dosage form
    containing amobarbital, secobarbital, or
    pentobarbital is in this schedule.

38
Controlled Substances
  • Schedule IV
  • Drugs in this schedule have an abuse potential
    less than those listed in Schedule III and
    include such drugs as barbital, phenobarbital,
    chloral hydrate, ethchlorvynol, meprobabmate,
    chlordizepoxide, diazepam, oxazepam,
    chloroazepate, flurazepam, etc.

39
Controlled Substances
  • Schedule V
  • Drugs in this schedule have an abuse potential
    less than those listed in Schedule IV and consist
    primarily of preparations containing limited
    quantities of certain narcotic analgesic drugs
    used for antitussive and antidiarrheal purposes.

40
Requirements for Prescriptions Written for
Controlled Substances
  • Required Information on the Prescription
  • Must be dated and signed on the day it is issued.
    Must have the full name and address of the
    patient.
  • Must have the name, address, and registration
    number of the physician.
  • May be prepared by the secretary, but must be
    signed by the physician.

41
Refilling Prescriptions for Controlled Substances
  • Refills for Schedule II drugs are not permitted.
  • Refills for Schedule III, IV, and V drugs are
    permitted if the number of refills is indicated
    on the prescription. However, the prescription
    order may be renewed only up to five times within
    six months after the date of issue. After five
    renewals or after six months a new prescription
    order is required.
Write a Comment
User Comments (0)
About PowerShow.com